nicorandil has been researched along with Diabetic Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, RJ; Kitagawa, W; Klawitter, J; Lanaspa, MA; Makino, H; Mathieson, PW; Miyazaki, M; Nakagawa, T; Rivard, CJ; Saleem, MA; Schreiner, GF; Tanabe, K | 1 |
1 other study(ies) available for nicorandil and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.
Topics: Animals; Antioxidants; Apoptosis; Blood Pressure; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicorandil; Nitric Oxide Donors; Nitric Oxide Synthase Type III; Oxidative Stress; Podocytes; Reactive Oxygen Species; Severity of Illness Index; Streptozocin | 2012 |